1121 Spring Lake Dr.
60143-32 Itasca, IL, us
National Safety Council: No Level of Cannabis Use Acceptable for Those Who Work in Safety Sensitive Positions
Organization calls on employers to prioritize safety as they navigate changing cannabis laws
“Research clearly shows that cannabis impacts a person’s psychomotor skills and cognitive ability,” said Lorraine M. Martin, president and CEO of the National Safety Council. “In order to protect our employees and those around them, we need to acknowledge the impairing effects of cannabis. We urge employers to implement policies stating no amount of cannabis consumption is acceptable for those who work in safety sensitive positions.”
In a 2019 NSC survey, employers expressed the following about cannabis:
81% were concerned about the drug having a negative impact on their workforce
71% indicated their organization’s written policies cover employee use of illicit cannabis, while only 54% said their policies cover employee use of legal or prescribed cannabis
24% indicated they would dismiss an employee found to be misusing legal cannabis, such as being under the influence while on the job, while only 7% said they would relocate the employee to a position of lesser responsibility
Studies have shown that those under the influence of cannabis can experience impaired body movement, altered senses, difficulty with thinking and problem-solving, impaired memory, an altered sense of time, changes in mood, and – when taken in high doses – hallucinations and delusions. Physical effects can include difficulty breathing and increased heart rate. These effects can lead to deadly consequences for those working in safety sensitive positions and those around them. NSC supports moving employees to non-safety sensitive operational positions when using cannabis for medical purposes.
Marijuana is the most frequently used illicit drug of abuse in the U.S. and the drug most often detected in workplace drug testing. Although cannabis remains federally illegal under the Controlled Substances Act as a Schedule I drug, NSC calls for an increase in cannabis research to discover a way to detect cannabis impairment and gain a better understanding of the effects the drug has on the human mind and body.
The new NSC policy position can be found here. More information about addressing cannabis in the workplace can be found here.
 NSC National Employer Survey 2019: Opioid Usage In The Workplace
 NIDA - https://www.drugabuse.gov/publications/drugfacts/marijuana
 NIDA - www.drugabuse.gov/publications/research-reports/marijuana/what-scope-marijuana-use-in-united-states
 Quest Diagnostics - www.questdiagnostics.com/home/physicians/health-trends/drug-testing.html
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an email@example.com.